Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by JGP Global Gestao de Recursos Ltda.

JGP Global Gestao de Recursos Ltda. raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 45.4% in the 4th quarter, HoldingsChannel reports. The fund owned 2,810 shares of the medical equipment provider’s stock after acquiring an additional 878 shares during the period. Intuitive Surgical makes up 3.3% of JGP Global Gestao de Recursos Ltda.’s investment portfolio, making the stock its 6th largest position. JGP Global Gestao de Recursos Ltda.’s holdings in Intuitive Surgical were worth $1,467,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $82,517,000. Exome Asset Management LLC increased its holdings in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Consolidated Planning Corp increased its holdings in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in shares of Intuitive Surgical by 73.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock worth $132,657,000 after buying an additional 114,149 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 1.4 %

Shares of NASDAQ:ISRG opened at $571.88 on Monday. The company has a fifty day simple moving average of $550.40 and a 200 day simple moving average of $509.43. The firm has a market cap of $203.69 billion, a PE ratio of 89.22, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 28,843 shares of company stock worth $15,357,560. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on ISRG shares. Evercore ISI upped their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Piper Sandler restated an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Citigroup raised their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Mizuho raised their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.